You are here

JNJ

By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years

Pharma Voice

Thu, 01/16/25 - 11:02 am

Intra-Cellular Therapeutics

J&J to buy psychiatric drug developer Intra-Cellular for $14.6B

BioPharma Dive

Mon, 01/13/25 - 11:19 am

Intra-Cellular Therapies

psychiatric disease

Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex

Fierce Pharma

Thu, 01/9/25 - 11:55 am

Multiple Myeloma

J&J Halts PFA Cases Amid Stroke Reports

Medical Devices and Diagnostics Industry

Wed, 01/8/25 - 11:18 pm

pulse field ablation

J&J says its lung cancer drug combination keeps people alive longer

CNBC

Tue, 01/7/25 - 11:13 am

clinical trials

Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23

Fierce Biotech

Mon, 01/6/25 - 10:58 am

Bristol Myers Squibb

How pharma was instrumental in President Jimmy Carter’s global health efforts

Pharma Voice

Fri, 01/3/25 - 09:57 am

6 Critical Developments That Could Define the Medical Device Industry in 2025

Medical Devices and Diagnostics Industry

Thu, 01/2/25 - 11:20 am

robotic surgery

PFA to surpass radiofrequency ablation in 2025: Citi survey

Medtech Dive

Tue, 12/17/24 - 12:01 pm

pulsed field ablation

radiofrequency ablation

Boston Scientific

FDA dents J&J's blockbuster hopes for Rybrevant

Pharmaphorum

Tue, 12/17/24 - 11:53 am

ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases

Fierce Pharma

Thu, 12/12/24 - 11:44 pm

Gilead Sciences

Gilead/Arcellx’s anito-cel’s differentiated safety profile challenges J&J/Legend’s Carvykti

BioSpace

Tue, 12/10/24 - 11:41 am

Gilead Sciences

Multiple Myeloma

ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep

Fierce Pharma

Mon, 12/9/24 - 09:10 pm

Multiple Myeloma

Johnson and Johnson Submits FDA Request for Pediatric Tremfya Approval

Managed Healthcare Executive

Mon, 12/2/24 - 07:17 pm

juvenile psoriatic arthritis

As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK

Fierce Pharma

Fri, 11/22/24 - 11:51 am

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll

Fierce Pharma

Wed, 11/20/24 - 08:41 pm

Prostate cancer: Three drug trials to watch

Clinical Trials Arena

Tue, 11/19/24 - 11:22 am

prostate cancer

clinical trials

Candel Therapeutics

Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis

Clinical Trials Arena

Tue, 11/19/24 - 11:00 am

clinical trials

J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial

Clinical Trials Arena

Fri, 11/15/24 - 11:02 am

Sjögren’s syndrome

Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court

MedCity News

Wed, 11/13/24 - 09:48 pm

Pages